Compare PECO & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PECO | MMSI |
|---|---|---|
| Founded | 1991 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.9B |
| IPO Year | 2010 | 1996 |
| Metric | PECO | MMSI |
|---|---|---|
| Price | $39.25 | $82.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | $38.71 | ★ $105.89 |
| AVG Volume (30 Days) | ★ 891.5K | 532.9K |
| Earning Date | 05-06-2026 | 03-24-2026 |
| Dividend Yield | ★ 3.31% | N/A |
| EPS Growth | ★ 74.51 | 25.31 |
| EPS | 0.89 | ★ 1.49 |
| Revenue | $726,594,000.00 | ★ $1,356,514,000.00 |
| Revenue This Year | $6.22 | $13.67 |
| Revenue Next Year | $3.89 | $6.16 |
| P/E Ratio | ★ $44.10 | $55.17 |
| Revenue Growth | ★ 9.86 | 7.89 |
| 52 Week Low | $32.40 | $77.62 |
| 52 Week High | $39.27 | $107.27 |
| Indicator | PECO | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 71.18 | 50.43 |
| Support Level | $37.85 | $80.78 |
| Resistance Level | $38.58 | $83.00 |
| Average True Range (ATR) | 0.66 | 2.22 |
| MACD | 0.10 | 0.38 |
| Stochastic Oscillator | 98.06 | 89.50 |
Phillips Edison & Co Inc is a real estate investment trust. The company also operates a third-party investment management business providing property management and advisory services to four unconsolidated institutional joint ventures, in which it has a partial ownership interest, and one private fund. It invests in well-occupied, grocery-anchored neighborhood and community shopping centers. It holds an integrated in-house operating platform built on a market of expertise designed to optimize property value and consistently deliver a great shopping experience.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.